P Holland Alday, Erin V McConnell, Jan M Boitz Zarella, Rozalia A Dodean, Papireddy Kancharla, Jane X Kelly, J Stone Doggett
ACS infectious diseases 2021 Jul 09Acridone derivatives, which have been shown to have in vitro and in vivo activity against Plasmodium spp, inhibit Toxoplasma gondii proliferation at picomolar concentrations. Using enzymatic assays, we show that acridones inhibit both T. gondii cytochrome bc1 and dihydroorotate dehydrogenase and identify acridones that bind preferentially to the Qi site of cytochrome bc1. We identify acridones that have efficacy in a murine model of systemic toxoplasmosis. Acridones have potent activity against T. gondii and represent a promising new class of preclinical compounds.
P Holland Alday, Erin V McConnell, Jan M Boitz Zarella, Rozalia A Dodean, Papireddy Kancharla, Jane X Kelly, J Stone Doggett. Acridones Are Highly Potent Inhibitors of Toxoplasma gondii Tachyzoites. ACS infectious diseases. 2021 Jul 09;7(7):1877-1884
PMID: 33723998
View Full Text